If a patient is being considered for percutaneous coronary intervention (PCI), what loading doses of antiplatelet and anticoagulant medications should be administered?

Loading Doses for PCI

For patients undergoing PCI, administer aspirin 162-325 mg orally and a P2Y12 inhibitor loading dose: clopidogrel 600 mg, prasugrel 60 mg, or ticagrelor 180 mg orally. 1

Aspirin Loading

• Loading dose: 162-325 mg orally 1
• Use chewable formulation when treating acute coronary syndrome for faster absorption 1
• Maintenance dose after PCI: 75-100 mg daily (doses <100 mg provide the best safety and efficacy balance) 1

P2Y12 Inhibitor Selection and Dosing

The choice depends on clinical presentation and patient characteristics:

Clopidogrel

• Loading dose: 600 mg orally 1
• Maintenance: 75 mg daily 1
• The 600 mg dose is superior to 300 mg, particularly in STEMI patients undergoing primary PCI, showing significantly reduced infarct size, better TIMI flow, improved left ventricular function, and fewer 30-day adverse events 2
• Critical timing consideration: The 600 mg dose achieves adequate platelet inhibition in approximately 2 hours, versus 6+ hours needed with 300 mg 3
• Only P2Y12 inhibitor studied after fibrinolytic therapy 1

Prasugrel

• Loading dose: 60 mg orally 1
• Maintenance: 10 mg daily (reduce to 5 mg if weight <60 kg or age ≥75 years) 1
• More potent than clopidogrel for ACS patients undergoing PCI 1

Ticagrelor

• Loading dose: 180 mg orally 1
• Maintenance: 90 mg twice daily 1
• Can be chewed for faster action 1
• More potent than clopidogrel for ACS patients 1
• Requires low-dose aspirin (<100 mg) based on PLATO study analysis 1

Timing of Administration

Contemporary evidence supports loading with P2Y12 inhibitors after coronary anatomy is known rather than routine pretreatment, particularly in NSTE-ACS patients undergoing early angiography 1. This approach:

• Offers similar clinical benefit to preloading 1, 4
• Allows for informed drug selection based on anatomy
• The ARMYDA-5 trial demonstrated that in-laboratory loading (given after angiography but before PCI) had equivalent 30-day outcomes compared to 4-8 hour preloading 4

Common pitfall: Don't delay PCI waiting for clopidogrel to "kick in" after loading—ad hoc PCI immediately after 900 mg clopidogrel loading showed no difference in outcomes compared to waiting 2 hours 5

Glycoprotein IIb/IIIa Inhibitors (Bailout Option)

Consider for high-risk situations or inadequate P2Y12 inhibition:

• Eptifibatide: Double bolus of 180 mcg/kg (10 minutes apart), then 2.0 mcg/kg/min infusion for up to 18 hours 1
• Tirofiban: Bolus 25 mcg/kg over 3 minutes, then 0.15 mcg/kg/min for up to 18 hours 1
• Abciximab: May not be readily available in the United States 1

Anticoagulation

While not explicitly a "loading dose," initiate procedural anticoagulation with one of the following (based on your institutional protocol and clinical scenario):

• Unfractionated heparin
• Enoxaparin
• Bivalirudin
• Fondaparinux (avoid in PCI due to catheter thrombosis risk) 3

Key principle: The combination of aspirin plus a potent P2Y12 inhibitor (prasugrel or ticagrelor) is preferred over clopidogrel for ACS patients, while clopidogrel remains appropriate for stable ischemic heart disease and post-fibrinolytic patients 1.